0000950170-24-057822.txt : 20240510
0000950170-24-057822.hdr.sgml : 20240510
20240510161136
ACCESSION NUMBER: 0000950170-24-057822
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240510
DATE AS OF CHANGE: 20240510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Andrea Carrie
CENTRAL INDEX KEY: 0001977969
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 24934962
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-649-9272
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4/A
1
ownership.xml
4/A
X0508
4/A
2024-05-06
2024-05-08
0001444192
Acasti Pharma Inc.
ACST
0001977969
D'Andrea Carrie
103 CARNEGIE CENTER
SUITE 300
PRINCETON
NJ
08540
false
true
false
false
VP Clinical Operations
false
Stock Options (Right to Buy)
2.96
2024-05-06
4
A
false
19740
0
A
2034-05-06
Class A Common Shares
19740
19740
D
This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory.
Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.
/s/ Carrie D'Andrea
2024-05-10